Viagra experienced no impact on saquinavir pharmacokinetics. A more powerful CYP3A4 inhibitor which include ketoconazole or itraconazole may very well be anticipated to obtain larger impact than that observed with saquinavir. Populace pharmacokinetic data from clients in medical trials also indicated a discount in sildenafil clearance when it had b